↓ Skip to main content

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study

Overview of attention for article published in BMC Cancer, May 2013
Altmetric Badge

Citations

dimensions_citation
34 Dimensions

Readers on

mendeley
58 Mendeley